Klar Fulgentes Pasilaban, FNP

Klar Pasilaban practices at Eastland Sub-Acute & Rehabilitation Center in El Monte, California.

Klar Pasilaban's NPI, 1104371806, was assigned on August 23, 2016. Klar Pasilaban holds California license 95004610.

Klar Pasilaban's primary practice is Eastland Sub-Acute & Rehabilitation Center, at 3825 Durfee Ave, El Monte, CA 91732 in Los Angeles County. The practice phone is (626) 444-2535.

Klar Pasilaban's primary practice is Eastland Sub-Acute & Rehabilitation Center in El Monte, California. Klar Pasilaban is also affiliated with Adventist Health Simi Valley. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Klar Pasilaban to 2 more hospitals, 7 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Klar Pasilaban practices, 6 sites in all. Vendor and product names are available with a free account.

Primary care is Klar Pasilaban's primary specialty in the NPI Registry, under taxonomy code 363LP2300X. Dmand AI has Klar Pasilaban's licenses on file in 6 states: California, Arizona, New Mexico, Nevada, Oregon and Washington.

Dmand AI lists acute skin infection, ankle or foot injury, broken or dislocated ankle/ or foot, bronchitis, bursitis, conjunctivitis, ear infection and enthesopathy in foot or ankle among the conditions Klar Pasilaban treats.

CMS data shows 149 Medicare services from Klar Pasilaban across 7 procedure codes in 2024, for 90 Medicare patients. Medicare paid $6,008 for them. Every service was in an office.

CMS counts 90 Medicare patients who saw Klar Pasilaban in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 37% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Klar Pasilaban's median patient age at 16, with 50% women.

In 2024, Klar Pasilaban wrote 239 Medicare Part D claims for 131 patients. 83% of them were for generic drugs. CMS names the drug for 114 of them, across 5 drugs with 11 or more claims each, at $1,183 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Klar Pasilaban for performance year 2024, reported through an alternative payment model (APM). Klar Pasilaban accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Klar Pasilaban from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Phadia US Inc. paid the most, $15.